Ajovy vs Emgality — Comparison & Availability
| Ajovy | Emgality | |
|---|---|---|
| Brand Name | Ajovy | Emgality |
| Generic Name | fremanezumab | galcanezumab |
| Drug Class | CGRP monoclonal antibody | CGRP monoclonal antibody |
| Findability Score | 52/100 | 40/100 |
| Findability | Moderate | Difficult |
| Avg Pharmacy Calls | ~15 | ~19 |
Which Is Easier to Find Right Now?
Ajovy is currently easier to find with a Findability Score of 52/100 (Moderate), compared to Emgality at 40/100 (Difficult).
On average, you'll need to call about 15 pharmacies to find Ajovy, versus 19 pharmacies for Emgality. If you're having trouble finding either, FindUrMeds can search for you.
Key Differences Between Ajovy and Emgality
Both Ajovy (fremanezumab) and Emgality (galcanezumab) belong to the CGRP monoclonal antibody drug class. While they share a similar mechanism of action, they may differ in dosing schedules, side effect profiles, and how individual patients respond to each. Your doctor can help determine which is the better fit based on your specific needs.
Frequently Asked Questions
Is Ajovy or Emgality easier to find?
Based on current availability data, Ajovy has a Findability Score of 52/100 compared to Emgality's 40/100. Ajovy typically requires about 15 pharmacy calls to locate, while Emgality may take around 19 calls.
Can I switch from Ajovy to Emgality?
Switching between Ajovy and Emgality requires a conversation with your prescribing doctor. They can evaluate whether the switch is appropriate based on your medical history, current condition, and how you've responded to your current medication. Never switch medications without medical guidance.
Which is cheaper, Ajovy or Emgality?
Prices vary by pharmacy, insurance coverage, and whether a generic is available. Ajovy (generic: fremanezumab) and Emgality (generic: galcanezumab) may have different out-of-pocket costs depending on your plan. Using GoodRx coupons or asking your pharmacist about generic alternatives can help reduce costs for either medication.
Summarize this article with AI: